LIBRIUM
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Jul 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
2/8 — Basic
Drug data last refreshed 7h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LIBRIUM is an injectable medication approved in 1961 with an unknown mechanism of action and pharmacologic class. The specific indications and therapeutic targets are not documented in available data. Patient populations and clinical uses cannot be determined from the provided information.
LOE Approaching
Product is in late-stage lifecycle with LOE approaching, signaling potential downsizing of commercial teams and reallocation to pipeline assets.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Started May 2026
20 enrolled
Major Depressive Disorder
Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN
Started Aug 2014
140 enrolled
Complications; Cesarean SectionAnesthesia; Reaction
Career Relevance
LIBRIUM currently shows zero linked job openings, reflecting its LOE-approaching lifecycle status and minimal commercial prioritization. Career opportunities on this asset are limited and declining, with roles likely being consolidated or eliminated in preparation for product transition.
Brand Manager
Worked on LIBRIUM at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.